Loading organizations...
Loading organizations...
Biotech company developing novel anticancer compounds targeting p53.
Aprea has raised $147.2M across 4 funding rounds.
Aprea has raised $147.2M in total across 4 funding rounds.
Aprea has raised $147.2M in total across 4 funding rounds.
Aprea's investors include Redmile Group, 5AM Ventures, HealthCap, Janus Henderson Investors, Karolinska Development, Rock Springs Capital, Sectoral Asset Management, Versant Ventures, Viktor Drvota, Scott Rocklage, Johan Christenson, guido magni.
Aprea has raised $147.2M across 4 funding rounds. Most recently, it raised $34.0M Other Equity in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 11, 2024 | $34.0M Other Equity | ||
| Feb 27, 2019 | $5.7M Series C | Redmile Group | 5AM Ventures, HealthCap, Janus Henderson Investors, Karolinska Development, Rock Springs Capital, Sectoral Asset Management, Versant Ventures |
| Nov 30, 2018 | $56.8M Series C | Redmile Group | 5AM Ventures, HealthCap, Viktor Drvota, Rock Springs Capital, Sectoral Asset Management, Versant Ventures |
| Mar 9, 2016 | $50.7M Series B | Scott Rocklage, Johan Christenson, guido magni | Sectoral Asset Management |